Analysis

  • July’s top news stories

    Zirabev gets FDA approval to treat five types of cancer and Dundee University and Bukwang to develop Parkinson’s drug. Pharmaceutical-technology.com wraps up key headlines from June 2019.

Close
Close
Close

Go Top